600165 Ningxia Zhongke Biotechnology
- 1.64
- +0.08+5.13%
Ningxia Zhongke Biotechnology News
*ST Ningke Stock Trading Risk Warning Notice
*ST Ningke's Notice on Receiving the Court's Decision to Initiate the Pre-Reorganization of the Company and Designate a Temporary Manager
*ST Ningke Stock Trading Abnormal Fluctuation and Risk Warning
Reply to the “Ningxia Zhongke Biotechnology Co., Ltd. Stock Trading Abnormal Fluctuations Inquiry Letter”
*ST Ningke's announcement on receiving a letter of supervision from an independent director
*ST Ningke Stock Trading Abnormal Fluctuation and Risk Warning
Reply to the “Ningxia Zhongke Biotechnology Co., Ltd. Stock Trading Abnormal Fluctuations Inquiry Letter”
*ST Ningke Stock Trading Risk Warning Notice
*ST Ningke received the announcement of the “Information Disclosure Regulatory Inquiry Letter on the 2023 Annual Report of Ningxia Zhongke Biotechnology Co., Ltd.”
*ST Ningke Stock Trading Risk Warning Notice
*Announcement of Resolutions of ST Ningke's 2023 Annual General Meeting of Shareholders
Legal Opinion on the 2023 Annual General Meeting of Shareholders of Ningxia Zhongke Biotechnology Co., Ltd.
*ST Ningke Stock Trading Risk Warning Notice
*ST Ningke's announcement on the early maturity of the company's loans
*Notice on ST Ningke's response to the Shanghai Stock Exchange's supervisory work letter on matters relating to the dismissal of the company's executives and directors from carrying out their duties
Legal Opinion of Shanghai Junlan Law Firm on the 24th Meeting of the 9th Board of Directors of Ningxia Zhongke Biotechnology Co., Ltd.
*ST Ningke Stock Trading Abnormal Fluctuation and Risk Warning
Reply to the “Ningxia Zhongke Biotechnology Co., Ltd. Stock Trading Abnormal Fluctuations Inquiry Letter”
*ST Ningke Major Litigation Notice
*ST Ningke's announcement on early maturing of some of its subsidiary bank loans
Analysis
Price Target
No Data
